🇺🇸 FDA

Company profile · Sponsor

Heron

Heron Therapeutics

HRTX · NYSE pharma SAN DIEGO, CA, EU
Pipeline
18
Drugs
2
Patents
8

Quick answer

Heron (HRTX) is a pharma company. headquartered in SAN DIEGO, CA, EU. listed on NYSE. NovaPharmaNews links 18 pipeline programs, 2 drugs, and 8 patents to this profile..

Company facts

Ticker HRTX
Exchange NYSE
Company type pharma
Headquarters SAN DIEGO, CA, EU
SEC CIK 0000818033

Pipeline (18)

Search pipeline →

  1. APF530

    Heron

    Chemotherapy-induced Nausea and Vomiting

    phase 3 small molecule completed

    1 trial

  2. APF530

    Heron

    Nausea and Vomiting

    phase 3 small molecule completed

    1 trial

  3. Aprepitant injectable emulsion

    Heron

    COVID-19

    phase 2 small molecule terminated

    1 trial

  4. B10 L-BPA Injection

    Heron

    Malignant Brain Tumors

    phase 2 small molecule active

    1 trial

  5. B10 L-BPA Injection

    Heron

    Meningioma

    phase 2 small molecule completed

    1 trial

  6. Bupivacaine HCI without epinephrine

    Heron

    Post-Operative Pain

    phase 2 small molecule completed

    1 trial

  7. Drug: B10 L-BPA Injection

    Heron

    Head and Neck Cancer

    phase 2 small molecule active

    1 trial

  8. GRANISETRON EXTENDED RELEASE INJECTION (GERSC)

    Heron

    Chemotherapy-induced Nausea and Vomiting

    phase 2 small molecule terminated

    1 trial

  9. HTX-011A

    Heron

    Postoperative Pain

    phase 2 small molecule completed

    1 trial

  10. HTX-011B

    Heron

    Postoperative Pain

    phase 2 small molecule completed

    1 trial

  11. HTX-034

    Heron

    Bunions

    phase 2 small molecule completed

    1 trial

  12. Bupivacaine HCl

    Heron

    Analgesia

    approved small molecule completed

    1 trial

  13. Bupivacaine Hydrochloride

    Heron

    Analgesia

    approved small molecule active

    1 trial

  14. Bupivacaine liposome injectable suspension

    Heron

    Analgesia

    approved small molecule completed

    1 trial

  15. HTX-011

    Heron

    Postoperative Pain

    approved small molecule completed

    8 trials

  16. HTX-011

    Heron

    Analgesia

    approved small molecule completed

    6 trials

  17. SUSTOL

    Heron

    Chemotherapy-Induced Nausea and Vomiting (CINV)

    approved small molecule active

    1 trial

  18. ZYNRELEF 200Mg-6Mg Extended-Release Solution

    Heron

    Post Operative Pain, Acute

    approved small molecule active

    1 trial

Drugs (2)

Search drugs →

  1. aprepitant

    EMEND

    ORAL approved

    A04AD12

  2. granisetron

    SANCUSO

    SUBCUTANEOUS approved

    A04AA02

Patents (8)

Search patents →

  1. US 12318376

    Compositions of a polyorthoester and an aprotic solvent

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12290520

    Methods of use of emulsion formulations of aprepitant

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12115255

    Methods of use of emulsion formulations of an NK-1 receptor antagonist

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12115254

    Methods of use of emulsion formulations of an NK-1 receptor antagonist

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11878074

    Methods of use of emulsion formulations of an NK-1 receptor antagonist

    Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11844837

    Compositions of a polyorthoester and an organic acid excipient

    Expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11744800

    Methods of use of emulsion formulations of an NK-1 receptor antagonist

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11413350

    Long-acting polymeric delivery systems

    Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Heron?

Heron (HRTX) is a pharma company. headquartered in SAN DIEGO, CA, EU. listed on NYSE. NovaPharmaNews links 18 pipeline programs, 2 drugs, and 8 patents to this profile..

What pipeline programs does Heron sponsor?

We track 18 ClinicalTrials.gov-linked programs for Heron, including APF530 and 17 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Heron company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.